QT VASCULAR LTD.

(Company Registration No. 201305911K)

(Incorporated in Singapore)

ATTEMPT BY MISSION WELL LIMITED AND TANSRI SARIDJU BENUI TO CONVENE ANOTHER EXTRAORDINARY GENERAL MEETING TO PROPOSE SAME RESOLUTIONS TO APPOINT NEW DIRECTORS ALREADY VOTED DOWN BY SHAREHOLDERS ON 6 DECEMBER 2021

  1. The Board of Directors ("Directors") of QT Vascular Ltd ("Company") refers to its announcement of the results of the extraordinary general meeting ("EGM") by the Company dated 6 December 2021 in respect of resolutions proposed by Mission Well Limited and Tansri Saridju Benui ("Requisitioning Shareholders").
  2. The Requisitioning Shareholders had proposed the appointments of Tansri Saridju Benui, Christian Kwok-Leun Yau Heilesen, Leung Yu Tung Stanley, Zhou Jia Lin and Chay Yiowmin as new directors of the Company for shareholders to vote on.
  3. SHAREHOLDERS HAD VOTED DOWN EACH AND EVERY ONE OF THESE RESOLUTIONS AT THE EGM ON 6 DECEMBER 2021, AND REJECTED THE APPOINTMENTS OF THESE NOMINEE DIRECTORS OF THE REQUISITIONING SHAREHOLDERS.
  4. The EGM on 6 December 2021 concluded at 9:52 a.m..
  5. On the same day at 1:12 p.m., the Company received an email from Christian Kwok-Leun Yau Heilesen attempting to call for another EGM of the Company to vote on these same resolutions ("Second Attempt EGM"), which had been voted down and rejected by shareholders not more than 4 hours ago.
  6. The Company intends to seek an explanation from the Requisitioning Shareholders for attempting the Second Attempt EGM, which resolutions were identical to those voted down by shareholders on the same day. The Company is surprised and disappointed that the Requisitioning Shareholders have blatantly ignored and disrespected the decision and will of shareholders voting at the EGM on 6 December 2021, which ought to have been final in respect of the matters then considered.
  7. Since receiving notification of the Second Attempt EGM, the Company has been in consultation with its professional advisers to determine the validity of this attempt to convene the Second Attempt EGM.
  8. The Company will continue to make the necessary announcements to update shareholders on material developments as and when appropriate.
  9. IN THE MEANTIME, SHAREHOLDERS AND OTHER INVESTORS ARE ADVISED TO EXERCISE CAUTION WHEN DEALING IN THE SECURITIES OF THE COMPANY. SHAREHOLDERS AND OTHER INVESTORS ARE ADVISED TO READ ANY ANNOUNCEMENTS BY THE COMPANY CAREFULLY. THEY SHOULD CONSULT THEIR STOCKBROKERS, BANK MANAGERS, SOLICITORS, ACCOUNTANTS, TAX ADVISORS OR OTHER PROFESSIONAL ADVISORS IF THEY ARE IN ANY DOUBT AS TO THE ACTIONS THEY SHOULD TAKE.

By Order of the Board of Directors

QT VASCULAR LTD.

Sho Kian HIn

Independent Director

7 December 2021

This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. ("Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Lim Hui Ling, 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318, sponsorship@ppcf.com.sg.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

QT Vascular Ltd. published this content on 07 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 December 2021 13:51:05 UTC.